Single-cell transcriptomics and machine learning unveil liquid-liquid phase separation-related biomarkers in HPV-positive cervical cancer
Specific cell stress patterns uniquely mark HPV-caused cervical cancer, offering a novel potential diagnostic angle requiring further development.
Analyzing 70,519 single-cell transcriptomes, this study identifies a specific LLPS-linked pattern — ribosomal protein suppression (RPL5, RPL11) — as distinguishing HPV-positive cervical malignancy from non-viral cancer and normal infection, with ML validation achieving moderate classification accuracy (69.7%). While novel mechanistically, external validation and improved diagnostic accuracy are required before clinical application.
What the study was
- Study design
- Single-center; 70,519 single-cell transcriptomes across 4 histological conditions (Normal/Cancer × HPV+/-); Random Forest ML classification; discovery-only (no external validation)
- Population
- Cervical cancer patients; single-cell transcriptomic data (scRNA-seq from public datasets or institutional samples)
- Category
- Diagnostics
- Maturity
- Exploratory
- Journal
- Infectious Agents and Cancer
Why it surfaced
Large scRNA-seq analysis (70,519 cells) with novel mechanistic LLPS-cancer link in HPV+ cervical cancer. ML accuracy (69.7%) is insufficient for clinical biomarker. Score capped at 6 by single-author study (potential quality concern), no external validation, and modest classification performance.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.